A detailed history of Raymond James & Associates transactions in Mckesson Corp stock. As of the latest transaction made, Raymond James & Associates holds 176,675 shares of MCK stock, worth $99.4 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
176,675
Previous 164,559 7.36%
Holding current value
$99.4 Million
Previous $96.1 Million 9.15%
% of portfolio
0.05%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$479.06 - $630.38 $5.8 Million - $7.64 Million
12,116 Added 7.36%
176,675 $87.3 Million
Q2 2024

Jul 19, 2024

BUY
$518.81 - $607.81 $3.6 Million - $4.22 Million
6,944 Added 4.41%
164,559 $96.1 Million
Q1 2024

Apr 22, 2024

BUY
$473.42 - $539.26 $2.1 Million - $2.39 Million
4,435 Added 2.9%
157,615 $84.6 Million
Q4 2023

Jan 16, 2024

BUY
$437.42 - $470.64 $3.84 Million - $4.13 Million
8,784 Added 6.08%
153,180 $70.9 Million
Q3 2023

Oct 24, 2023

BUY
$402.4 - $446.42 $214,479 - $237,941
533 Added 0.37%
144,396 $62.8 Million
Q2 2023

Jul 25, 2023

BUY
$354.01 - $427.31 $360,736 - $435,428
1,019 Added 0.71%
143,863 $61.5 Million
Q1 2023

Apr 14, 2023

SELL
$335.35 - $386.06 $1.72 Million - $1.98 Million
-5,119 Reduced 3.46%
142,844 $50.9 Million
Q4 2022

Feb 08, 2023

SELL
$346.68 - $397.58 $1.61 Million - $1.85 Million
-4,651 Reduced 3.05%
147,963 $55.5 Million
Q3 2022

Oct 25, 2022

BUY
$321.25 - $373.84 $6.97 Million - $8.11 Million
21,691 Added 16.57%
152,614 $51.9 Million
Q2 2022

Aug 12, 2022

SELL
$300.57 - $336.42 $748,719 - $838,022
-2,491 Reduced 1.87%
130,923 $42.7 Million
Q1 2022

May 11, 2022

SELL
$244.61 - $310.48 $7.71 Million - $9.79 Million
-31,535 Reduced 19.12%
133,414 $40.8 Million
Q4 2021

Feb 08, 2022

BUY
$198.21 - $248.9 $4.21 Million - $5.29 Million
21,249 Added 14.79%
164,949 $41 Million
Q3 2021

Nov 02, 2021

BUY
$188.42 - $208.66 $2.4 Million - $2.66 Million
12,731 Added 9.72%
143,700 $28.7 Million
Q2 2021

Aug 11, 2021

SELL
$184.89 - $202.68 $10.4 Million - $11.4 Million
-56,215 Reduced 30.03%
130,969 $25 Million
Q1 2021

May 14, 2021

SELL
$169.52 - $196.53 $4.76 Million - $5.52 Million
-28,106 Reduced 13.05%
187,184 $36.5 Million
Q4 2020

Feb 12, 2021

SELL
$143.79 - $183.66 $3.87 Million - $4.94 Million
-26,886 Reduced 11.1%
215,290 $37.4 Million
Q3 2020

Nov 04, 2020

BUY
$140.89 - $159.9 $1.25 Million - $1.42 Million
8,898 Added 3.81%
242,176 $36.1 Million
Q2 2020

Jul 28, 2020

SELL
$125.49 - $164.68 $4.25 Million - $5.58 Million
-33,898 Reduced 12.69%
233,278 $35.8 Million
Q1 2020

Apr 21, 2020

BUY
$115.75 - $170.96 $2.4 Million - $3.54 Million
20,710 Added 8.4%
267,176 $36.1 Million
Q4 2019

Feb 12, 2020

SELL
$130.23 - $153.27 $3.31 Million - $3.9 Million
-25,452 Reduced 9.36%
246,466 $34.1 Million
Q3 2019

Nov 07, 2019

BUY
$134.24 - $148.53 $1.98 Million - $2.19 Million
14,723 Added 5.72%
271,918 $37.2 Million
Q2 2019

Aug 06, 2019

SELL
$112.47 - $134.93 $415,464 - $498,431
-3,694 Reduced 1.42%
257,195 $34.6 Million
Q1 2019

May 06, 2019

BUY
$111.86 - $136.3 $4.49 Million - $5.47 Million
40,105 Added 18.16%
260,889 $30.5 Million
Q4 2018

Feb 11, 2019

SELL
$108.23 - $136.84 $3.14 Million - $3.97 Million
-29,033 Reduced 11.62%
220,784 $24.4 Million
Q3 2018

Nov 14, 2018

BUY
$123.14 - $138.52 $4.9 Million - $5.51 Million
39,804 Added 18.95%
249,817 $33.1 Million
Q2 2018

Aug 14, 2018

BUY
$133.4 - $158.13 $3.39 Million - $4.02 Million
25,439 Added 13.78%
210,013 $28 Million
Q1 2018

May 14, 2018

BUY
$138.75 - $176.72 $9.42 Million - $12 Million
67,883 Added 58.17%
184,574 $26 Million
Q4 2017

Feb 14, 2018

BUY
$135.02 - $162.6 $949,460 - $1.14 Million
7,032 Added 6.41%
116,691 $18.2 Million
Q3 2017

Nov 13, 2017

SELL
$146.0 - $161.87 $242,360 - $268,704
-1,660 Reduced 1.49%
109,659 $16.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
111,319
111,319 $18.3 Million

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $80.9B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.